🇺🇸 FDA
Patent

US 8420099

Chimeric protein for prevention and treatment of HIV infection

granted A61KA61K39/395

Quick answer

US patent 8420099 (Chimeric protein for prevention and treatment of HIV infection) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K39/395